News

aeruginosa infection can often receive adequate ... commercially available intravenous products. NA: Not available. Cystic fibrosis (CF) pulmonary disease is characterized by chronic and recurrent ...
This latter concept is considered with particular reference to Pseudomonas aeruginosa, which is often found in the airway secretions of patients with non-cystic fibrosis bronchiectasis and may act as ...
In a small study, CF patients treated with the therapy saw a reduction in multidrug-resistant lung bacteria and improved lung ...
The project is dedicated to safeguarding US vaccine use so that it remains grounded in the best available science, free from ...
Shares in Vertex have soared after the company announced that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time. The company is a pioneer in ...
Vertex could be close to a price deal with the NHS over its portfolio of cystic fibrosis drugs, after health ministers wrote to the US firm asking for a conclusion to talks after almost two years ...
Preclinical research involves the evaluation of potential therapeutic interventions in cells and animals. Candidates for entry into clinical trials can then be selected based on their ...
Victoria is now home to Australia's first centre dedicated to supporting people with cystic fibrosis. Minister for Economic Growth and Jobs Danny Pearson today announced the Cystic Fibrosis Centre of ...
Share this restaurant in Twitter Share this restaurant in Facebook Share this restaurant in WhatsApp Share this restaurant in Messenger Share this restaurant by email Francesca Falzon, a Maltese ...
As the mother of a son and daughter living with cystic fibrosis, now both young adults, I’ve walked this path, navigating chronic illness and discovering how vital mental health support is for the ...
eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...